GlassScriptPhysician profile
Timothy A Deimling
NPI 1316173982
$181,946.93
in general payments reported to CMS, 2019-2025
10 companies · $2,624 in 2025
The $2,624 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115K · 2020: $42K · 2021: $18K · 2022: $3,783 · 2023: $64.15 · 2024: $521 · 2025: $2,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,711 · Education: $750 · Food and Beverage: $749.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,710.57 |
| Education | $750.00 |
| Food and Beverage | $748.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171,505.86 | 2019-2023 | Orilissa |
| Pfizer INC. | $3,516.38 | 2022-2023 | |
| Alnylam Pharmaceuticals INC. | $3,120.00 | 2021 | |
| Intuitive Surgical, INC. | $1,791.49 | 2019-2025 | |
| Distalmotion US | $1,600.46 | 2025 | Dexter L6 Robot |
| Medtronic, INC. | $264.23 | 2021-2022 | |
| Ethicon US, LLC | $128.73 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $19.78 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Deimling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.